These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

466 related items for PubMed ID: 18793958

  • 1. L-DOPA preloading increases the uptake of borophenylalanine in C6 glioma rat model: a new strategy to improve BNCT efficacy.
    Capuani S, Gili T, Bozzali M, Russo S, Porcari P, Cametti C, D'Amore E, Colasanti M, Venturini G, Maraviglia B, Lazzarino G, Pastore FS.
    Int J Radiat Oncol Biol Phys; 2008 Oct 01; 72(2):562-7. PubMed ID: 18793958
    [Abstract] [Full Text] [Related]

  • 2. Boronophenylalanine uptake in C6 glioma model is dramatically increased by L-DOPA preloading.
    Capuani S, Gili T, Bozzali M, Russo S, Porcari P, Cametti C, Muolo M, D'Amore E, Maraviglia B, Lazzarino G, Pastore FS.
    Appl Radiat Isot; 2009 Jul 01; 67(7-8 Suppl):S34-6. PubMed ID: 19375337
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Quantitative imaging and microlocalization of boron-10 in brain tumors and infiltrating tumor cells by SIMS ion microscopy: relevance to neutron capture therapy.
    Smith DR, Chandra S, Barth RF, Yang W, Joel DD, Coderre JA.
    Cancer Res; 2001 Nov 15; 61(22):8179-87. PubMed ID: 11719448
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Molecular targeting of the epidermal growth factor receptor for neutron capture therapy of gliomas.
    Barth RF, Yang W, Adams DM, Rotaru JH, Shukla S, Sekido M, Tjarks W, Fenstermaker RA, Ciesielski M, Nawrocky MM, Coderre JA.
    Cancer Res; 2002 Jun 01; 62(11):3159-66. PubMed ID: 12036929
    [Abstract] [Full Text] [Related]

  • 7. The effect of dexamethasone on the uptake of p-boronophenylalanine in the rat brain and intracranial 9L gliosarcoma.
    Morris GM, Micca PL, Coderre JA.
    Appl Radiat Isot; 2004 Nov 01; 61(5):917-21. PubMed ID: 15308168
    [Abstract] [Full Text] [Related]

  • 8. Neutron capture therapy of a rat glioma using boronophenylalanine as a capture agent.
    Matalka KZ, Barth RF, Staubus AE, Moeschberger ML, Coderre JA.
    Radiat Res; 1994 Jan 01; 137(1):44-51. PubMed ID: 8265787
    [Abstract] [Full Text] [Related]

  • 9. Hydroxylforms of p-boronophenylalanine as potential boron carriers on boron neutron capture therapy for malignant brain tumors.
    Takagaki M, Ono K, Oda Y, Kikuchi H, Nemoto H, Iwamoto S, Cai J, Yamamoto Y.
    Cancer Res; 1996 May 01; 56(9):2017-20. PubMed ID: 8616843
    [Abstract] [Full Text] [Related]

  • 10. Suitability of boron carriers for BNCT: accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA.
    Chou FI, Chung HP, Liu HM, Chi CW, Lui WY.
    Appl Radiat Isot; 2009 Jul 01; 67(7-8 Suppl):S105-8. PubMed ID: 19375330
    [Abstract] [Full Text] [Related]

  • 11. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of either sodium borocaptate or boronophenylalanine with or without blood-brain barrier disruption.
    Barth RF, Yang W, Rotaru JH, Moeschberger ML, Joel DD, Nawrocky MM, Goodman JH, Soloway AH.
    Cancer Res; 1997 Mar 15; 57(6):1129-36. PubMed ID: 9067283
    [Abstract] [Full Text] [Related]

  • 12. Analysis of boron distribution in vivo for boron neutron capture therapy using two different boron compounds by secondary ion mass spectrometry.
    Yokoyama K, Miyatake S, Kajimoto Y, Kawabata S, Doi A, Yoshida T, Okabe M, Kirihata M, Ono K, Kuroiwa T.
    Radiat Res; 2007 Jan 15; 167(1):102-9. PubMed ID: 17214510
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of pharmacokinetics of 4-borono-2-(18)F-fluoro-L-phenylalanine for boron neutron capture therapy in a glioma-bearing rat model with hyperosmolar blood-brain barrier disruption.
    Hsieh CH, Chen YF, Chen FD, Hwang JJ, Chen JC, Liu RS, Kai JJ, Chang CW, Wang HE.
    J Nucl Med; 2005 Nov 15; 46(11):1858-65. PubMed ID: 16269600
    [Abstract] [Full Text] [Related]

  • 14. Selective uptake of p-boronophenylalanine by osteosarcoma cells for boron neutron capture therapy.
    Ferrari C, Zonta C, Cansolino L, Clerici AM, Gaspari A, Altieri S, Bortolussi S, Stella S, Bruschi P, Dionigi P, Zonta A.
    Appl Radiat Isot; 2009 Jul 15; 67(7-8 Suppl):S341-4. PubMed ID: 19394838
    [Abstract] [Full Text] [Related]

  • 15. Boron neutron capture therapy of brain tumors: enhanced survival and cure following blood-brain barrier disruption and intracarotid injection of sodium borocaptate and boronophenylalanine.
    Barth RF, Yang W, Rotaru JH, Moeschberger ML, Boesel CP, Soloway AH, Joel DD, Nawrocky MM, Ono K, Goodman JH.
    Int J Radiat Oncol Biol Phys; 2000 Apr 01; 47(1):209-18. PubMed ID: 10758326
    [Abstract] [Full Text] [Related]

  • 16. In vitro neutron irradiation of glioma and endothelial cultured cells.
    Menichetti L, Gaetano L, Zampolli A, Del Turco S, Ferrari C, Bortolussi S, Stella S, Altieri S, Salvadori PA, Cionini L.
    Appl Radiat Isot; 2009 Jul 01; 67(7-8 Suppl):S336-40. PubMed ID: 19410472
    [Abstract] [Full Text] [Related]

  • 17. Boronated epidermal growth factor as a delivery agent for neutron capture therapy of EGF receptor positive gliomas.
    Yang W, Barth RF, Wu G, Bandyopadhyaya AK, Thirumamagal BT, Tjarks W, Binns PJ, Riley K, Patel H, Coderre JA, Ciesielski MJ, Fenstermaker RA.
    Appl Radiat Isot; 2004 Nov 01; 61(5):981-5. PubMed ID: 15308179
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetic study of BSH and BPA in simultaneous use for BNCT.
    Yokoyama K, Miyatake S, Kajimoto Y, Kawabata S, Doi A, Yoshida T, Asano T, Kirihata M, Ono K, Kuroiwa T.
    J Neurooncol; 2006 Jul 01; 78(3):227-32. PubMed ID: 16557351
    [Abstract] [Full Text] [Related]

  • 19. Selective delivery of boron by the melanin precursor analogue p-boronophenylalanine to tumors other than melanoma.
    Coderre JA, Glass JD, Fairchild RG, Micca PL, Fand I, Joel DD.
    Cancer Res; 1990 Jan 01; 50(1):138-41. PubMed ID: 2293547
    [Abstract] [Full Text] [Related]

  • 20. Boron neutron capture therapy of EGFR or EGFRvIII positive gliomas using either boronated monoclonal antibodies or epidermal growth factor as molecular targeting agents.
    Yang W, Barth RF, Wu G, Tjarks W, Binns P, Riley K.
    Appl Radiat Isot; 2009 Jul 01; 67(7-8 Suppl):S328-31. PubMed ID: 19467880
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.